Trading Tips Blog

Activist investor adds $2 million to existing stake. On Tuesday, activist investor Ron Perelman revealed the additional purchase of 1.2 million shares in a company he already owns more than 10 percent of, vTv Therapeutics (VTVT). Perelman now owns over 20.2 million shares of the company. The shares were purchased at an average price of $1.65, but shares currently trade around $1.45, so anyone looking to piggyback on the billionaire investor can get a bargain here. The company may not be for all ...
Read More

Majority owner and manager adds to stake. On Monday, iStar, the majority owner of Safehold (SAFE), added to their stake. As the majority owner of the company already, and the manager of Safehold, the move is an indication that shares of the company remain undervalued. iStar picked up an additional 15,000 shares, representing a cost of about $468,000. This buy leaves iStar with over 20.6 million shares of Safehold. The buys occurred with shares at a 52-week high, another unusual sign but another ...
Read More

Big bet on massive rally in energy company. While the summer is typically a slow season for stocks, one trader is betting on a big move in shares of Hess (HES). With shares currently around $61, there’s been a surge in trading on the January 2020 $80 calls, indicating a 30 percent upside in shares between now and January. Over 16,000 of those contracts traded on Tuesday, about a 20-fold increase in volume for prior trading. Hess is an explorer and producer of ...
Read More

Director buys over $900,000 in shares. Insiders have been a bit more active in the leisure space lately. Besides some of the insider buys we’ve seen in the casino industry, we’re now seeing insiders buy in the leisure travel space. On Wednesday July 3rd, director Randall Weisenburger bought 20,000 shares of the company he sits on the board of, Carnival Corp (CCL). This is a 20 percent increase in his stake, and he paid about $930,000 to make the deal. Weisinburger’s buy comes ...
Read More

Big bearish bet on tech giant in the next month. Shares of Apple (AAPL) sold off Monday on a major downgrade, citing the company’s “fundamental deterioration.” Naturally, some traders saw that as an opportunity to sell shares—at least in the short-term. That explains the 100-fold increase in volume on the August 2nd $185 puts on the company. With shares of Apple trading just under $200, this is a bet on about a 7.5 percent decline between now and expiration in 25 days. Apple ...
Read More

Big bet on social media company rallying in the next month. Shares of social media companies have underperformed the broad market. Between a slowdown in user growth and privacy concerns, they don’t look like the most attractive investment. Yet shares of these companies are off their recent lows—and at least one trader is betting on a big move higher. Last Friday saw a surge in volume on the July 26th $19 call options on Snapchat (SNAP). With shares trading around $15, that’s a ...
Read More

Major holder adds to stake in blood testing company. Insiders in the health, pharmaceutical, and biotech space continue to buy shares of their beaten-down companies near today’s prices. The latest big buy? At shares of one of the smaller diagnostic plays, OncoCyte Corporation (OCX). Last week, Broadwood Partners LP, which already owns more than 10 percent of shares in the company, added 1 million shares to their stake. At a price of around $2, this represented a $2 million buy. Founded in 2009, OncoCyte ...
Read More

There are a lot of ways to make money in the market. But even if you find that rare company that can move ten-fold and provide one of the best profits of your lifetime, that will take time.Most investors get impatient. Trading Tips’ Andrew Packer explains why you should be looking at blue-chip bargains ...
Read More